Public, Private Health Concerns Spur Rapid Progress In Toxicology

Increasing fears about carcinogens and other poisons will fuel further growth in the already booming field, experts say The science of toxicology has come a long way in a relatively short time. Back in 1961, when a fledgling society of researchers devoted to the study of poisons and their effect on the human body was well-formed enough to merit holding an annual meeting, the group had 161 members. Next week, as the Society of Toxicology (SOT) convenes its 31st annual meeting, its membership

Written byMarcia Clemmitt
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Next week, as the Society of Toxicology (SOT) convenes its 31st annual meeting, its membership totals more than 3,100, double what it was just seven years ago. And for the first time in its history, with attendance expected to top 4,000, the event will be held in a convention center--in this case the huge Seattle Convention Center.

Another sign of the discipline's growth: At this year's meeting--which runs February 23-27--some 1,600 research advances are to be presented in platform discussions and poster sessions. That is 20 percent more than were put forth only a year ago.

Accompanying this quantitative growth, however, is an equally notable qualitative broadening, stemming in large part from burgeoning demands by industry, government, and the public for more information about the chemical risks that exist around us. To empower their field's stepped-up move toward maturity, toxicologists are embracing new scientific techniques from disciplines such as molecular ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies